Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRICHLORMETHIAZIDE Cause Respiratory tract infection? 96 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Respiratory tract infection have been filed in association with TRICHLORMETHIAZIDE. This represents 28.1% of all adverse event reports for TRICHLORMETHIAZIDE.

96
Reports of Respiratory tract infection with TRICHLORMETHIAZIDE
28.1%
of all TRICHLORMETHIAZIDE reports
0
Deaths
96
Hospitalizations

How Dangerous Is Respiratory tract infection From TRICHLORMETHIAZIDE?

Of the 96 reports, 96 (100.0%) required hospitalization.

Is Respiratory tract infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRICHLORMETHIAZIDE. However, 96 reports have been filed with the FAERS database.

What Other Side Effects Does TRICHLORMETHIAZIDE Cause?

Dyspnoea (105) Cough (104) Drug ineffective (103) Obstructive airways disorder (103) Pneumonia (101) Bronchial secretion retention (97) Eosinophil count increased (97) Multiple allergies (97) Pulmonary mass (97) Sputum culture positive (97)

What Other Drugs Cause Respiratory tract infection?

RITUXIMAB (1,058) PREDNISONE (1,051) OMALIZUMAB (927) ADALIMUMAB (913) METHOTREXATE (895) ETANERCEPT (848) HUMAN IMMUNOGLOBULIN G (764) LENALIDOMIDE (731) DEXAMETHASONE (684) ALBUTEROL (601)

Which TRICHLORMETHIAZIDE Alternatives Have Lower Respiratory tract infection Risk?

TRICHLORMETHIAZIDE vs TRICLOSAN TRICHLORMETHIAZIDE vs TRIENTINE TRICHLORMETHIAZIDE vs TRIENTINE TETRAHYDROCHLORIDE TRICHLORMETHIAZIDE vs TRIFAROTENE TRICHLORMETHIAZIDE vs TRIFLUOPERAZINE

Related Pages

TRICHLORMETHIAZIDE Full Profile All Respiratory tract infection Reports All Drugs Causing Respiratory tract infection TRICHLORMETHIAZIDE Demographics